75 related articles for article (PubMed ID: 32891477)
1. Spontaneous Regression of Recurrent Respiratory Papillomatosis with HPV Vaccination: A Case Study.
Nyirjesy S; Osmundson P; Matrka L
J Voice; 2022 Jul; 36(4):587.e21-587.e25. PubMed ID: 32891477
[TBL] [Abstract][Full Text] [Related]
2. Human Papillomavirus Vaccination as an Adjuvant Therapy for Recurrent Respiratory Papillomatosis: Additional Case Series.
Matsuzaki H; Makiyama K; Hasegawa H; Asai R; Morita M; Oshima T
J Voice; 2024 Jan; 38(1):204-209. PubMed ID: 34600799
[TBL] [Abstract][Full Text] [Related]
3. Human papilloma virus (HPV) vaccination is associated with reduced number of surgical treatments, an observational study on recurrent respiratory papillomatosis in Northern Sweden.
Schindele A; Al-Sabtti S; Olofsson K
Acta Otolaryngol; 2024 Jan; 144(1):71-75. PubMed ID: 38484282
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant Human Papillomavirus Vaccination in Recurrent Respiratory Papilloma Patients Older than 45.
Ivancic R; Freeman T; de Silva B; Forrest A; Kim B; Matrka L
Laryngoscope; 2024 Jul; 134(7):3226-3229. PubMed ID: 38401115
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of combined approach to recurrent respiratory papillomatosis (RRP).
Aga A; Bekteshi E; Ajasllari G; Kosta A; Vajushi E; Kortoci R; Filauro M; Muka T; Peretti G
Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3693-3700. PubMed ID: 38637412
[TBL] [Abstract][Full Text] [Related]
6. The role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis.
Chen L; Hu H; Pan Y; Lu Y; Zhao M; Zhao Y; Wang L; Liu K; Yu Z
J Virol; 2024 May; 98(5):e0192523. PubMed ID: 38624230
[TBL] [Abstract][Full Text] [Related]
7. Recurrent respiratory papillomatosis: A 2020 perspective.
Benedict JJ; Derkay CS
Laryngoscope Investig Otolaryngol; 2021 Apr; 6(2):340-345. PubMed ID: 33869767
[TBL] [Abstract][Full Text] [Related]
8. A pilot study on salivary HPV DNA detection to monitor active disease from patients with recurrent respiratory papillomatosis.
Chantre-Justino M; Figueiredo MC; Alves G; Ornellas MHF
Am J Otolaryngol; 2024; 45(2):104157. PubMed ID: 38061173
[TBL] [Abstract][Full Text] [Related]
9. Our experience in developing and operating the Airway Intervention Registry for Recurrent Respiratory Papillomatosis (AIR-RRP): national data collection.
Sims A; Keltie K; Belilios E; Burn J; Brown L; Jackson A; Powell S; Jones S; Donne A
NIHR Open Res; 2022; 2():22. PubMed ID: 36855411
[TBL] [Abstract][Full Text] [Related]
10. Recurrent respiratory papillomatosis disease course in immunosuppressed populations.
Erickson EL; Freeman TE; Sun S; Koch B; Allen DZ; Sethia R; deSilva B; Matrka L
J Laryngol Otol; 2024 May; 138(5):576-580. PubMed ID: 37877153
[TBL] [Abstract][Full Text] [Related]
11. Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Institution's Experience.
So RJ; Rayle C; Joo HH; Huang EY; Seiwert TY; Raabe EH; Best SR
Laryngoscope; 2024 Jul; 134(7):3253-3259. PubMed ID: 38525973
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review.
Sechi I; Muresu N; Di Lorenzo B; Saderi L; Puci M; Aliberti S; Maida I; Mondoni M; Piana A; Sotgiu G
Infect Dis Rep; 2024 Feb; 16(2):200-215. PubMed ID: 38525763
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with Iatrogenic Laryngeal Injury in Recurrent Respiratory Papillomatosis.
So RJ; Hillel AT; Motz KM; Akst LM; Best SR
Otolaryngol Head Neck Surg; 2024 Apr; 170(4):1091-1098. PubMed ID: 38123898
[TBL] [Abstract][Full Text] [Related]
14. Is there any interplay between human gut microbiota and upper airway susceptibility to recurrent respiratory papillomatosis exacerbations?
Klimza H; Jackowska J; Zagozda N; Wierzbicka M
Otolaryngol Pol; 2024 Jun; 78(3):1-6. PubMed ID: 38808640
[TBL] [Abstract][Full Text] [Related]
15. Global trends and hotspots on recurrent respiratory papillomatosis: A 20-year bibliometric analysis.
Wang C; Pan Y; Huang H; Liu K; Yu Z
Laryngoscope Investig Otolaryngol; 2024 Jun; 9(3):e1271. PubMed ID: 38835332
[TBL] [Abstract][Full Text] [Related]
16. Systemic bevacizumab for treatment of recurrent respiratory papillomatosis.
Zhao X; Wang J; Chen Q; Wu X; Mao W; Ma J; Fang R; He P; Wei C
Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1865-1875. PubMed ID: 38180605
[TBL] [Abstract][Full Text] [Related]
17. Cimetidine for recurrent respiratory papillomatosis in pregnancy as an alternative adjuvant treatment.
Tan SH; Ghauth S; Liew YT; Abu Bakar Z
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):1053-1055. PubMed ID: 38078971
[TBL] [Abstract][Full Text] [Related]
18. An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis.
Welschmeyer A; Berke GS
Laryngoscope Investig Otolaryngol; 2021 Apr; 6(2):226-233. PubMed ID: 33869755
[TBL] [Abstract][Full Text] [Related]
19. Recurrent respiratory papillomatosis with lung involvement.
Molodtsova V; Ryabova M; Dvorakovskaya I; Vasilyeva M; Akopov A
Respir Med Case Rep; 2018; 25():323-326. PubMed ID: 30406011
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
